If you are also suffering from a bacterial infection and have waited long enough for its natural recovery you may need a Swab ...

Pfizer announced the introduction of a novel treatment in the United Arab Emirates for adult patients with serious ...

This newly introduced therapy is designed to restore effectiveness against some of the most resistant pathogens ...

Blacksmith Medicines receives European patent for LpxC-targeting antibacterial compounds: San Diego, California Tuesday, November 25, 2025, 16:00 Hrs [IST] Blacksmith Medicines, I ...

GSK funding allocated to six new research programmes which will combine expertise and using cutting edge AI technology to ...

GSK is investing £45m with the Fleming Initiative to launch six research programmes using cutting-edge AI to tackle ...

The UK turns to artificial intelligence (AI) to reverse the rising numbers of infections that shrug off antibiotics.

The India Gentamycin market is driven by rising bacterial infections and antimicrobial resistance, supported by government ...

Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the European Patent Office has issued a ...

In recent years, superbugs have become a global threat to healthcare. Given the fatal nature, the UK scientists have come ...

Mortality was strongly associated with older age, comorbidities, and infection type, underscoring the need for early and diagnosis-specific antimicrobial intervention.